Long-term type VII collagen restoration to human epidermolysis bullosa skin tissue

Human Gene Therapy

Volumn 21, Issue 10, 2010, Pages 1299-1310

  Siprashvili, Zurab ^a   Nguyen, Ngon T ^a   Bezchinsky, Maria Y ^a   Marinkovich, M Peter ^a   Lane, Alfred T ^a   Khavari, Paul A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBRIL; COLLAGEN TYPE 7; COLLAGEN TYPE 7A1; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; EPIDERMOLYSIS BULLOSA; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NONHUMAN;

ANIMALS; CELL TRANSFORMATION, VIRAL; COLLAGEN; DNA, COMPLEMENTARY; EPIDERMOLYSIS BULLOSA DYSTROPHICA; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; KERATINOCYTES; MICE; MICE, SCID; MOLONEY MURINE LEUKEMIA VIRUS; SKIN; SKIN TRANSPLANTATION; TRANSDUCTION, GENETIC; TRANSGENES;

MUS;

EID: 77958109358     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2010.023     Document Type: Article

References (41)

1. Burgeson, R.E. (1993). Type VII collagen, anchoring fibrils, and epidermolysis bullosa. J. Invest. Dermatol. 101, 252-255.
2. Chen, M., Kasahara, N., Keene, D.R., Chan, L., Hoeffler, W.K., Finlay, D., Barcova, M., Cannon, P.M., Mazurek, C., and Woodley, D.T. (2002). Restoration of type VII collagen ex-pression and function in dystrophic epidermolysis bullosa. Nat. Genet. 32, 670-675.
3. Choate, K.A., Kinsella, T.M., Williams, M.L., Nolan, G.P., and Khavari, P.A. (1996a). Transglutaminase 1 delivery to lamellar ichthyosis keratinocytes. Hum. Gene Ther. 7, 2247-2253.
4. Choate, K.A., Medalie, D.A., Morgan, J.R., and Khavari, P.A. (1996b). Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat. Med. 2, 1263-1267.
5. Christiano, A.M., Greenspan, D.S., Lees, and Uitto, J. (1994a). Cloning of human type VII collagen. Complete primary se-quence of the a(VII) chain and identification of intragenic polymorphisms. J. Biol. Chem. 269, 20256-20262.
6. Christiano, A.M., Hoffman, G.G., Chung-Honet, L.C., Lee, S., Cheng, W., Uitto, J., and Greenspan, D.S. (1994b). Structural organization of the human type VII collagen gene (COL7A1), composed of more exons than any previously characterized gene. Genomics 21, 169-179.
7. De Luca, M., Albanese, E., Bondanza, S., Megna, M., Ugozzoli, L., Molina, F., Cancedda, R., Santi, P.L., Bormioli, M., Stella, M., and Magliacani, G. (1989). Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state. Burns 15, 303-309.
8. Deng, H., Lin, Q., and Khavari, P.A. (1997). Sustainable cuta-neous gene delivery. Nat. Biotechnol. 15, 1388-1391.
9. Deng, H., Choate, K.A., Un, Q., and Khavari, P.A. (1998). High-efficiency gene transfer and pharmacologic selection of ge-netically engineered human keratinocytes. Biotechniques 25, 274-280.
10. Di Nunzio, F., Maruggi, G., Ferrari, S., Di Iorio, E., Poletti, V., Garcia, M., Del Rio, M., De Luca, M., Larcher, F., Pellegrini, G., and Mavilio, F. (2008). Correction of laminin-5 deficiency in human epidermal stern cells by transcriptionally targeted lentiviral vectors. Mol. Ther. 16, 1977-1985.
11. Eady, R.A., and Dunnill, M.G. (1994). Epidermolysis bullosa: Hereditary skin fragility diseases as paradigms in cell biology. Arch. Dermatol. Res. 287, 2-9.
12. Edinger, M., Svveeney, T.J., Tucker, A.A., Olomu, A.B., Negrin, R.S., and Contag, C.H. (1999). Noninvasive assessment of tu-mor cell proliferation in animal models. Neoplasia 1, 303-310.
13. Gache, Y., Baldeschi, C., Del Rio, M., Gagnoux-Palacios, L., Larcher, F., Lacour, J.P., and Meneguzzi, G. (2004). Construc-tion of skin equivalents for gene therapy of recessive dystrophic epidermolysis bullosa. Hum. Gene Ther. 15, 921-933.
14. Green, H. (1980). The keratinocyte as differentiated cell type. Harvey Lect. 74, 101-139.
15. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., Le Deist, F., Wulffraat, N., Mcintyre, E., Radford, I., Villeval, J.L., Fraser, C.C., Cavazzana-Calvo, M., and Fischer, A. (2003a). A serious adverse event after successful gene therapy for X-linked se-vere combined immunodeficiency. N. Engl. J. Med. 348, 255-256.
16. Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Mac-intyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., and Cavazzana-Calvo, M. (2003b). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302, 415-419.
17. Heagerty, A.H., Kennedy, A.R., Leigh, I.M., Purkis, P., and Eady, R.A. (1986). Identification of an epidermal basement membrane defect in recessive forms of dystrophic epidermo-lysis bullosa by LH 7:2 monoclonal antibody: Use in diagnosis. Br. J. Dermatol. 115, 125-131.
18. Kern, J.S., Loeckermann, S., Fritsch, A., Hausser, L., Roth, W., Magin, T.M., Mack, C., Muller, M.L., Paul, O., Ruther, P., and Bruckner-Tuderman, L. (2009). Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: High stability of collagen VII favors long-term skin integrity. Mol. Ther. 17, 1605-1615.
19. Kinsella, T.M., and Nolan, G.P. (1996). Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7, 1405-1413.
20. Kohn, D.B., Sadelain, M., Dunbar, C., Bodine, D., Kiem, H.P., Candotti, F., Tisdale, J., Riviere, I., Blau, C.A., Richard, R.E., Sorrentino, B., Nolta, J., Malech, H., Brenner, M., Cornetta, K., Cavagnaro, J., High, K., Glorioso, J.; American Society of Gene Therapy (ASGT). (2003). American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol. Ther. 8, 180-187.
21. Korge, B.P., and Krieg, T. (1996). The molecular basis for in-herited bullous diseases. J. Mol. Med. 74, 59-70.
22. Lapiere, J.C., Woodley, D.T., Parente, M.G., Iwasaki, T., Wynn, K.C., Christiano, A.M., and Uitto, J. (1993). Epitope mapping of type VII collagen: Identification of discrete peptide se-quences recognized by sera from patients with acquired epi-dermolysis bullosa. J. Clin. Invest. 92, 1831-1839.
23. Leigh, I.M., Eady, R.A., Heagerty, A.H., Purkis, P.E., Whitehead, P.A., and Burgeson, R.E. (1988). Type VII collagen is a normal component of epidermal basement membrane, which shows altered expression in recessive dystrophic epidermolysis bul-losa. J. Invest. Dermatol. 90, 639-642.
24. Marinkovich, M.P. (1993). The molecular genetics of basement membrane diseases. Arch. Dermatol. 129, 1557-1565.
25. Mavilio, F., Pellegrini, G., Ferrari, S., Di Nunzio, F., Di Iorio, E., Recchia, A., Maruggi, G., Ferrari, G., Provasi, E., Bonini, C., Capurro, S., Conti, A., Magnoni, C., Giannetti, A., and De Luca, M. (2006). Correction of junctional epidermolysis bul-losa by transplantation of genetically modified epidermal stem cells. Nat. Med. 12, 1397-1402.
26. Miller, A.D., Garcia, J.V., Von Suhr, N., Lynch, C.M., Wilson, C., and Eiden, M.V. (1991). Construction and properties of ret-rovirus packaging cells based on gibbon ape leukemia virus. J. Virol. 65, 2220-2224.
27. Ortiz-Urda, S., Thyagarajan, B., Keene, D.R., Un, Q., Fang, M., Calos, M.P., and Khavari, P.A. (2002). Stable nonviral genetic correction of inherited human skin disease. Nat. Med. 8,1166-1170.
28. Ortiz-Urda, S., Lin, Q., Green, C.L., Keene, D.R., Marinkovich, M.P., and Khavari, P.A. (2003). Injection of genetically en-gineered fibroblasts corrects regenerated human epidermo-lysis bullosa skin tissue. J. Clin. Invest. 111, 251-255.
29. Ortiz-Urda, S., Garcia, J., Green, C.L., Chen, L., Un, Q., Veitch, D.P., Sakai, L.Y., Lee, H., Mariniovich, M.P., and Khavari, P.A. (2005). Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307, 1773-1776.
30. Paller, A.S. (1996). The genetic basis of hereditary blistering disorders. Curr. Opin. Pediatr. 8, 367-371.
31. Pellegrini, G., Bondanza, S., Guerra, L., and De Luca, M. (1998). Cultivation of human keratinocyte stem cells: Current and future clinical applications. Med. Biol. Eng. Comput. 36, 778-790.
32. Remington, J., Wang, X., Hou, Y., Zhou, H., Burnett, J., Muir-head, T., Uitto, J., Keene, D.R., Woodley, D.T., and Chen, M. (2009). Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystro-phic epidermolysis bullosa. Mol. Ther. 17, 26-33.
33. Robbins, P.B., Lin, Q., Goodnough, J.B., Tian, F.L., Chen, X., and Khavari, P.A. (2001). In vivo restoration of laminin 5 ß3 ex-pression and function in junctional epidermolysis bullosa. Proc. Natl. Acad. Sci. U.S.A. 98, 5193-5198.
34. Seitz, C.S., Giudice, G.J., Balding, S.D., Marinkovich, M.P., and Khavari, P.A. (1999). BP180 gene delivery in junctional epi-dermolysis bullosa. Gene Ther. 6, 42-47.
35. Thompson, J.F., Hayes, L.S., and Lloyd, D.B. (1991). Modulation of firefly luciferase stability and impact on studies of gene regulation. Gene 103, 171-177.
36. Tolar, J., Ishida-Yamamoto, A., Riddle, M., McElmurry, R.T., Osborn, M., Xia, L., Lund, T., Slattery, C., Ditto, J., Christiano, A.M., Wagner, J.E., and Blazar, B.R. (2009). Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells. Blood 113, 1167-1174.
37. Uitto, J., and Pulkkinen, L. (1996). Molecular complexity of the cutaneous basement membrane zone. Mol. Biol. Rep. 23, 35-46.
38. Wong, T., Gammon, L., Liu, L., Mellerio, J.E., Dopping-Hepen-stal, P.J., Pacy, J., Elia, G., Jeffery, R., Leigh, I.M., Navsaria, H., and McGrath, J.A. (2008). Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J. Invest. Der-matol. 128, 2179-2189.
39. Woodley, D.T., Krueger, G.G., Jorgensen, C.M., Fairley, J.A., Atha, T., Huang, Y., Clian, L., Keene, D.R., and Chen, M. (2003). Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone. J. Invest. Dermatol. 121,1021-1028.
40. Woodley, D.T., Keene, D.R., Atha, T., Huang, Y., Lipman, K., Li, W., and Chen, M. (2004a). Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat. Med. 10, 693-695.
41. Woodley, D.T., Keene, D.R., Atha, T., Huang, Y., Ram, R., Ka-sahara, N., and Chen, M. (2004b). Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epi-dermolysis bullosa skin tissue in vivo. Mol. Ther. 10, 318-326